About Us

Katerina Akassoglou, Ph.D.

Katerina Akassoglou, Ph.D. is the Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at the University of California, San Francisco and Gladstone Institutes, and the scientific founder of Therini Bio. Dr. Akassoglou’s laboratory discovered neurovascular and neuroimmune mechanisms of disease, and in particular the causal role of fibrin in neurological diseases. Dr. Akassoglou leveraged this knowledge to develop fibrin-targeting therapeutics to block its deleterious effects in inflammation and repair. Dr. Akassoglou is a leader in neuroscience and immunology, has published over 100 papers and book chapters and holds 20 issued and pending patents. Dr. Akassoglou is an elected Lifetime Fellow of the American Association for the Advancement of Science (AAAS), the National Academy of Inventors (NAI) and the American Society for Pharmacology and Experimental Therapeutics (ASPET). She received the Presidential Early Career Award for Scientists and Engineers by the White House, the John J. Abel Award by ASPET and Eli Lilly, the Dana Foundation Award, the Vilcek Prize in Creative Promise honor, The Marilyn Hilton Award for Innovation in MS Research, the NIH R35 Research Program and EUREKA Awards, the ISFP Prize and the Barancik Prize for Innovation in MS Research, and was named by the San Francisco Business Times in 2021 Most Influential Women in Bay Area Business.